UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma

Cell reports (Cambridge), 2019-09, Vol.28 (10), p.2501-2508.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14592-e14592

2023

Link zum Volltext

Verfügbarkeit prüfen

Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS) to enable correlation of targeted therapy combination response with clinical outcomes

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15574-e15574

2023

Link zum Volltext

Verfügbarkeit prüfen

A micro-organosphere potency assay for adoptive T-cell therapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15027-e15027

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroOrganoSpheres as a clinically applicable precision oncology platform for the discovery of novel therapies in colorectal cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3592-3592

2023

Link zum Volltext

Verfügbarkeit prüfen

Identifying targeted therapy combination for refractory colorectal cancer using micro-organospheres

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.27-27

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived micro-organospheres recapitulate tumor microenvironment and heterogeneity for precision oncology

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3076-3076

2021

Link zum Volltext

Verfügbarkeit prüfen

Micro-organospheres: An automated patient-derived model platform for rapid drug screening of breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12628-e12628

2021

Link zum Volltext

Verfügbarkeit prüfen

Microorganospheres as a novel precision oncology platform in colorectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.149-149

2022

Link zum Volltext

Verfügbarkeit prüfen

Micro-organospheres retain patient tumor microenvironment for precision immuno-oncology

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2573-2573

2022

Link zum Volltext

Verfügbarkeit prüfen

A precision medicine strategy to identify the FGFR pathway as a novel target in colorectal cancer liver metastasis

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.660-660

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived skin MicroOrganoSpheres and clinical response to immunotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2588-2588

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion

Surgery, 2023-08, Vol.174 (2), p.428-430

2023

Link zum Volltext

Verfügbarkeit prüfen

Improving Cancer Drug Discovery by Studying Cancer across the Tree of Life

Molecular biology and evolution, 2020-01, Vol.37 (1), p.11-17

2020

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications

Annals of surgery, 2022-12, Vol.276 (6), p.943

2022

Link zum Volltext

Verfügbarkeit prüfen

KEYlargo: A phase II study of first-line pembrolizumab (P), capecitabine (C), and oxaliplatin (O) in HER2-negative gastroesophageal (GE) adenocarcinoma

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.228-228

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3555-3555

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of actionable mutations in solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22149-e22149

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.160-160

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3548-3548

2016

Link zum Volltext

Verfügbarkeit prüfen

Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3611-3611

2014

Link zum Volltext

Verfügbarkeit prüfen

X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.687-687

2016

Link zum Volltext

Verfügbarkeit prüfen

A molecular profile of colorectal cancer to guide prognosis and therapy after resection of primary or metastatic disease

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.339-339

2013

Link zum Volltext

Verfügbarkeit prüfen

Discovering pathways in the tumor microenvironment important for recurrence-free survival in patients with colorectal liver metastasis

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.480-480

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictive and prognostic markers of recurrence after resection of primary or metastatic colorectal cancer

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.447-447

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma

A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease

Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS) to enable correlation of targeted therapy combination response with clinical outcomes

A micro-organosphere potency assay for adoptive T-cell therapy

MicroOrganoSpheres as a clinically applicable precision oncology platform for the discovery of novel therapies in colorectal cancer

Identifying targeted therapy combination for refractory colorectal cancer using micro-organospheres

Patient-derived micro-organospheres recapitulate tumor microenvironment and heterogeneity for precision oncology

Micro-organospheres: An automated patient-derived model platform for rapid drug screening of breast cancer

Microorganospheres as a novel precision oncology platform in colorectal cancer

Micro-organospheres retain patient tumor microenvironment for precision immuno-oncology

A precision medicine strategy to identify the FGFR pathway as a novel target in colorectal cancer liver metastasis

Patient-derived skin MicroOrganoSpheres and clinical response to immunotherapy

Hepatic artery infusion for unresectable colorectal cancer liver metastases: Palliation and conversion

Improving Cancer Drug Discovery by Studying Cancer across the Tree of Life

Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications

KEYlargo: A phase II study of first-line pembrolizumab (P), capecitabine (C), and oxaliplatin (O) in HER2-negative gastroesophageal (GE) adenocarcinoma

A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood

Identification and validation of actionable mutations in solid tumors

Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223

Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)

Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer

X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)

A molecular profile of colorectal cancer to guide prognosis and therapy after resection of primary or metastatic disease

Discovering pathways in the tumor microenvironment important for recurrence-free survival in patients with colorectal liver metastasis

Predictive and prognostic markers of recurrence after resection of primary or metastatic colorectal cancer

Suchergebnisse filtern